Literature DB >> 24675673

Deep sequencing with intronic capture enables identification of an APC exon 10 inversion in a patient with polyposis.

Brian H Shirts1, Stephen J Salipante1, Silvia Casadei2, Shawnia Ryan3, Judith Martin3, Angela Jacobson1, Tatyana Vlaskin1, Karen Koehler1, Robert J Livingston1, Mary-Claire King4, Tom Walsh2, Colin C Pritchard1.   

Abstract

PURPOSE: Single-exon inversions have rarely been described in clinical syndromes and are challenging to detect using Sanger sequencing. We report the case of a 40-year-old woman with adenomatous colon polyps too numerous to count and who had a complex inversion spanning the entire exon 10 in APC (the gene encoding for adenomatous polyposis coli), causing exon skipping and resulting in a frameshift and premature protein truncation.
METHODS: In this study, we employed complete APC gene sequencing using high-coverage next-generation sequencing by ColoSeq, analysis with BreakDancer and SLOPE software, and confirmatory transcript analysis.
RESULTS: ColoSeq identified a complex small genomic rearrangement consisting of an inversion that results in translational skipping of exon 10 in the APC gene. This mutation would not have been detected by traditional sequencing or gene-dosage methods.
CONCLUSION: We report a case of adenomatous polyposis resulting from a complex single-exon inversion. Our report highlights the benefits of large-scale sequencing methods that capture intronic sequences with high enough depth of coverage-as well as the use of informatics tools-to enable detection of small pathogenic structural rearrangements.

Entities:  

Mesh:

Year:  2014        PMID: 24675673      PMCID: PMC4752361          DOI: 10.1038/gim.2014.30

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  17 in total

1.  Parallel sequencing used in detection of mosaic mutations: comparison with four diagnostic DNA screening techniques.

Authors:  Anna Rohlin; Josephine Wernersson; Yvonne Engwall; Leif Wiklund; Jan Björk; Margareta Nordling
Journal:  Hum Mutat       Date:  2009-06       Impact factor: 4.878

2.  Detection of APC mutations by a yeast-based protein truncation test (YPTT).

Authors:  T Suzuki; C Ishioka; S Kato; Y Mitachi; H Shimodaira; M Sakayori; A Shimada; M Asamura; R Kanamaru
Journal:  Genes Chromosomes Cancer       Date:  1998-04       Impact factor: 5.006

3.  CREST maps somatic structural variation in cancer genomes with base-pair resolution.

Authors:  Jianmin Wang; Charles G Mullighan; John Easton; Stefan Roberts; Sue L Heatley; Jing Ma; Michael C Rusch; Ken Chen; Christopher C Harris; Li Ding; Linda Holmfeldt; Debbie Payne-Turner; Xian Fan; Lei Wei; David Zhao; John C Obenauer; Clayton Naeve; Elaine R Mardis; Richard K Wilson; James R Downing; Jinghui Zhang
Journal:  Nat Methods       Date:  2011-06-12       Impact factor: 28.547

4.  MUTYH-associated polyposis - variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations.

Authors:  M Morak; A Laner; U Bacher; C Keiling; E Holinski-Feder
Journal:  Clin Genet       Date:  2010-10       Impact factor: 4.438

5.  Detection of sequence variations in the adenomatous polyposis coli (APC) gene using denaturing high-performance liquid chromatography.

Authors:  G Wu; W Wu; M Hegde; M Fawkner; B Chong; D Love; L K Su; P Lynch; K Snow; C S Richards
Journal:  Genet Test       Date:  2001

6.  Identification and characterization of the familial adenomatous polyposis coli gene.

Authors:  J Groden; A Thliveris; W Samowitz; M Carlson; L Gelbert; H Albertsen; G Joslyn; J Stevens; L Spirio; M Robertson
Journal:  Cell       Date:  1991-08-09       Impact factor: 41.582

7.  Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens.

Authors:  Colin C Pritchard; Stephen J Salipante; Karen Koehler; Christina Smith; Sheena Scroggins; Brent Wood; David Wu; Ming K Lee; Suzanne Dintzis; Andrew Adey; Yajuan Liu; Keith D Eaton; Renato Martins; Kari Stricker; Kim A Margolin; Noah Hoffman; Jane E Churpek; Jonathan F Tait; Mary-Claire King; Tom Walsh
Journal:  J Mol Diagn       Date:  2013-11-02       Impact factor: 5.568

8.  Somatic APC mosaicism: an underestimated cause of polyposis coli.

Authors:  F J Hes; M Nielsen; E C Bik; D Konvalinka; J T Wijnen; E Bakker; H F A Vasen; M H Breuning; C M J Tops
Journal:  Gut       Date:  2007-06-29       Impact factor: 23.059

9.  BreakDancer: an algorithm for high-resolution mapping of genomic structural variation.

Authors:  Ken Chen; John W Wallis; Michael D McLellan; David E Larson; Joelle M Kalicki; Craig S Pohl; Sean D McGrath; Michael C Wendl; Qunyuan Zhang; Devin P Locke; Xiaoqi Shi; Robert S Fulton; Timothy J Ley; Richard K Wilson; Li Ding; Elaine R Mardis
Journal:  Nat Methods       Date:  2009-08-09       Impact factor: 28.547

10.  Rare mutations predisposing to familial adenomatous polyposis in Greek FAP patients.

Authors:  Markos Mihalatos; Angela Apessos; Hans Dauwerse; Voula Velissariou; Aristidis Psychias; Alexander Koliopanos; Konstantinos Petropoulos; John K Triantafillidis; Ioannis Danielidis; George Fountzilas; Niki J Agnantis; Georgios Nasioulas
Journal:  BMC Cancer       Date:  2005-04-15       Impact factor: 4.430

View more
  9 in total

Review 1.  Family-Specific Variants and the Limits of Human Genetics.

Authors:  Brian H Shirts; Colin C Pritchard; Tom Walsh
Journal:  Trends Mol Med       Date:  2016-10-11       Impact factor: 11.951

Review 2.  Emerging Role of Genomic Rearrangements in Breast Cancer: Applying Knowledge from Other Cancers.

Authors:  Bhavna S Paratala; Sonia C Dolfi; Hossein Khiabanian; Lorna Rodriguez-Rodriguez; Shridar Ganesan; Kim M Hirshfield
Journal:  Biomark Cancer       Date:  2016-02-11

3.  Searching the second hit in patients with inherited retinal dystrophies and monoallelic variants in ABCA4, USH2A and CEP290 by whole-gene targeted sequencing.

Authors:  María González-Del Pozo; Marta Martín-Sánchez; Nereida Bravo-Gil; Cristina Méndez-Vidal; Ángel Chimenea; Enrique Rodríguez-de la Rúa; Salud Borrego; Guillermo Antiñolo
Journal:  Sci Rep       Date:  2018-09-06       Impact factor: 4.379

4.  A distinct APC pathogenic germline variant identified in a southern Thai family with familial adenomatous polyposis.

Authors:  Worrawit Wanitsuwan; Sukanya Vijasika; Pichai Jirarattanasopa; Sukanya Horpaopan
Journal:  BMC Med Genomics       Date:  2021-03-19       Impact factor: 3.063

5.  Improving performance of multigene panels for genomic analysis of cancer predisposition.

Authors:  Brian H Shirts; Silvia Casadei; Angela L Jacobson; Ming K Lee; Suleyman Gulsuner; Robin L Bennett; Margaret Miller; Sarah A Hall; Heather Hampel; Fuki M Hisama; Lorraine V Naylor; Cathleen Goetsch; Kathleen Leppig; Jonathan F Tait; Sheena M Scroggins; Emily H Turner; Robert Livingston; Stephen J Salipante; Mary-Claire King; Tom Walsh; Colin C Pritchard
Journal:  Genet Med       Date:  2016-02-04       Impact factor: 8.822

6.  Three novel mutations of APC gene in Chinese patients with familial adenomatous polyposis.

Authors:  Qi Liu; Xiaoxia Li; Sen Li; Shengqiang Qu; Yu Wang; Qingzhu Tang; Hongwei Ma; Yang Luo
Journal:  Tumour Biol       Date:  2016-03-22

7.  Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary.

Authors:  Janos Papp; Marietta Eva Kovacs; Zoltan Matrai; Enikő Orosz; Miklós Kásler; Anne-Lise Børresen-Dale; Edith Olah
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

8.  Pseudoexons provide a mechanism for allele-specific expression of APC in familial adenomatous polyposis.

Authors:  Taina T Nieminen; Walter Pavicic; Noora Porkka; Matti Kankainen; Heikki J Järvinen; Anna Lepistö; Päivi Peltomäki
Journal:  Oncotarget       Date:  2016-10-25

Review 9.  Current status of the genetic susceptibility in attenuated adenomatous polyposis.

Authors:  Víctor Lorca; Pilar Garre
Journal:  World J Gastrointest Oncol       Date:  2019-12-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.